SKYRIZI
ABBVIE CORPORATION
View this drug's full profile page →
This is a national manufacturer shortage report. It does not confirm whether the product is unavailable at your local pharmacy — call ahead or ask your pharmacist.
Quick answers
Is SKYRIZI discontinued in Canada?
Yes. The manufacturer has reported to Health Canada that SKYRIZI 75MG has been permanently discontinued (last updated February 6, 2025). It is not expected to come back, so talk to your pharmacist or doctor about an alternative.
Other Products Containing the Same Active Ingredient
These are other Health Canada-approved human drug products containing the same active ingredient, not currently reported in shortage. Strength, dosage form, and route can still differ — ask your pharmacist whether any of these are appropriate for you. This isn't a guarantee of current stock.
Other Products
SKYRIZI
ABBVIE CORPORATION
What this means
Does this mean I need to switch medications right away?
Not necessarily right away, but this product will not be returning to the market.
What should I do?
Talk to your pharmacist or prescriber about your options well before your current supply runs out.
DIN
02487454
Strength
75MG
Dosage Form
SOLUTION
Route
SUBCUTANEOUS
Active Ingredient
RISANKIZUMAB
Tier
Unrated
Last Updated
2025-02-06
Reason for Shortage
Other (Please describe in comments)
Other Products from ABBVIE CORPORATION
Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.
35MG · DIN 02246896
150MG · DIN 02316838
35MG · DIN 02370417
0.5% · DIN 01968300
0.4% · DIN 02248722
0.45% · DIN 02369362
0.2% · DIN 02236876
0.15% · DIN 02248151
10MG · DIN 02443910
50UNIT · DIN 02531577
100UNIT · DIN 01981501
200UNIT · DIN 02531585